2 Pages
English

Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools, Says Frost & Sullivan

Gain access to the library to view online
Learn more

Description

Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools, Says Frost & Sullivan PR Newswire LONDON, May 30, 2012 - Lack of Venture Capital Infusions Threatens to Slow Pace of Research and Market Development LONDON, May 30, 2012 /PRNewswire/ -- Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments. New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), Strategic Analysis of the European Stem Cell Research Tools Market, finds that the market earned revenues of $148.4 million in 2011 and estimates this to reach $322.0 million in 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools. "Firms with the capacity to supply tools for stem cell research will increase as the science matures," notes Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. "Soon demand and supply will achieve a degree of equilibrium." Already, a sizeable stem cell research products market has emerged. Another positive sign for the market has been enhanced industry- academic collaboration. A key step forward has been the stem cell regulations in a few countries allowing the use of certain cell lines.

Subjects

Informations

Published by
Reads 6
Language English
Rapidly Evolving Stem Cells Market Opens Up
Doors for Related Research Tools, Says Frost
& Sullivan
PR Newswire
LONDON, May 30, 2012
- Lack of Venture Capital Infusions Threatens to Slow Pace of
Research and Market Development
LONDON
, May 30, 2012 /PRNewswire/ -- Stem cell research is very dynamic
with research trends, focus, and approaches evolving extremely rapidly. The
tool market has to quickly adapt to these challenges and develop innovative
tools that address and accelerate research accomplishments.
New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com),
Strategic Analysis of the European Stem Cell Research Tools Market
,
finds that the market earned revenues of
$148.4 million
in 2011 and estimates
this to reach
$322.0 million
in 2017. The segments covered include: bio-imaging
and microscopy, cell biology tools, immunochemical, molecular biology tools,
and protein biochemistry tools.
"Firms with the capacity to supply tools for stem cell research will increase as
the science matures," notes Frost & Sullivan Senior Research Analyst Divyaa
Ravishankar. "Soon demand and supply will achieve a degree of equilibrium."
Already, a sizeable stem cell research products market has emerged. Another
positive sign for the market has been enhanced industry- academic
collaboration.
A key step forward has been the stem cell regulations in a few countries
allowing the use of certain cell lines. In some countries such as
France
, for
instance, stem cell regulations are being renewed for the procurement and use
of stem cells.
"Such trends indicate the potential for a regulatory climate that would be far
less restrictive than the current scenario," adds Divyaa Ravishankar. "This,
together with the prospect of diverse applications within the healthcare arena,
is bolstering the future of the market."
However, the lack of venture capitalists (VC) poses a grave challenge. VC
funding is driven by investment concerns, with companies bidding to double
their money every few years in order to return revenue to the fund's investors.
As a high risk venture, stem cell technology does not exactly present an
attractive investment proposition.
"While these are financial concerns, from the technological standpoint, the
challenge remains to understand the basic biology behind stem cells," remarks
Divyaa Ravishankar. "There is an urgent need to design and develop specific
technology platforms that enhance the production, genetic stability and
integration of transplanted cells."
If you are interested in more information on this study, please send an e-mail
with your contact details to Janique Morvan, Corporate Communications, at
janique.morvan@frost.com.
Strategic Analysis of the European Stem Cell Research Tools Market
is
part of the
Clinical Diagnostics
Growth Partnership Services programme,